Comparative Analysis of MYB Expression by Immunohistochemistry and RNA Sequencing in Clinical Gene Fusion Detection in Adenoid Cystic Carcinoma
Head and Neck Pathology · 26.10.2024 · 18 (1)
DOI: 10.1007/s12105-024-01719-1 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Head and Neck Pathology, online erschienen am 26.10.2024. Verfasst von Adam S Fisch und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. afisch1@mgh.harvard.edu. Hauptthemen laut MEDLINE: Carcinoma, Adenoid Cystic, Immunohistochemistry, Proto-Oncogene Proteins c-myb, Biomarkers, Tumor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Adenoid Cystic Carcinoma Research Foundation, United States.
Abstract (Originalsprache)
PURPOSE: MYB has been shown to play a central role in oncogenesis in a majority of adenoid cystic carcinomas (ACC). Testing for MYB expression via immunohistochemistry (IHC) or testing for the MYB gene fusion by next-generation sequencing (NGS) have become useful tools for the diagnosis of ACC. In addition, detection of MYB expression may have implications for patient management. METHODS: A cohort of 35 ACC cases was identified from the archival pathology files of the Massachusetts General Hospital. Cases were tested for MYB expression using a panel of 4 different commercially available MYB antibodies and scored using a modified Allred system. RNA-based NGS for MYB gene fusion detection was also performed. RESULTS: Among 4 different MYB antibodies, the sensitivity for MYB detection ranged from 26 to 97%. When a 30% threshold for determination of MYB immunohistochemical positivity was used, the AB_10900735 IHC clone showed the maximum sensitivity (97%). RNA sequencing revealed 19 (54%) cases positive for MYB fusions, and expression analysis derived from the sequencing data confirmed a significant association between MYB expression and fusion status (p = 0.036). Although less sensitive, the AB_778878 MYB clone showed a significant positive association between IHC staining and MYB RNA expression (R2 = 0.15, p = 0.023). CONCLUSION: The detection of MYB expression using immunohistochemistry varies significantly depending on the antibody used. Comparison with MYB fusion and transcription levels, as determined by NGS, reveals that MYB has a complex relationship between genetic alterations, transcript levels, and protein abundance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. afisch1@mgh.harvard.edu.
- Immuto Scientific, Cambridge, MA, USA.
- Foundation Medicine, Inc, Boston, MA, USA.
- Departments of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
- BostonGene Corporation, Waltham, MA, USA.
- Department of Pathology, Massachusetts Eye and Ear, Boston, MA, USA.
Förderung
- Adenoid Cystic Carcinoma Research Foundation, United States
Zitieren
APA
Fisch, A. S., Farahani, A. A., Thierauf, J., Iafrate, A. J., Lennerz, J. K., & Faquin, W. C. (2024). Comparative Analysis of MYB Expression by Immunohistochemistry and RNA Sequencing in Clinical Gene Fusion Detection in Adenoid Cystic Carcinoma. Head and Neck Pathology, 18(1). https://doi.org/10.1007/s12105-024-01719-1
Vancouver
Fisch AS, Farahani AA, Thierauf J, Iafrate AJ, Lennerz JK, Faquin WC. Comparative Analysis of MYB Expression by Immunohistochemistry and RNA Sequencing in Clinical Gene Fusion Detection in Adenoid Cystic Carcinoma. Head and Neck Pathology. 2024;18(1). doi:10.1007/s12105-024-01719-1
BibTeX
@article{Fisch2024,
author = {Fisch, Adam S and Farahani, Alexander A and Thierauf, Julia and Iafrate, A John and Lennerz, Jochen K and Faquin, William C},
title = {Comparative Analysis of MYB Expression by Immunohistochemistry and RNA Sequencing in Clinical Gene Fusion Detection in Adenoid Cystic Carcinoma},
journal = {Head and Neck Pathology},
year = {2024},
volume = {18},
number = {1},
doi = {10.1007/s12105-024-01719-1}
}
EUVIMED